Pub Date : 2020-10-23eCollection Date: 2020-01-01DOI: 10.1530/VB-20-0012
Dwitiya Sawant, Brenda Lilly
miRNAs are small regulatory RNAs which govern gene expression post-transcriptionally by primarily binding to the 3'-UTR of mRNA target genes. miR-145 is a well-studied miRNA that has been implicated in controlling a range of biological processes. miR-145 is expressed in a variety of tissues and cell types and acts as a tumor-suppressor by regulating target gene signaling pathways involved in different aspects of tumor growth and progression. There is also strong evidence that highlights the important functions of miR-145 in the cardiovascular system. Here, we review the mechanisms of miR-145 in tumorigenesis and cancer progression and compare and contrast with the roles of miR-145 in cardiovascular development and disease. We discuss the important targets of miR-145 in cancer and their possible link to the cardiovascular system.
{"title":"MicroRNA-145 targets in cancer and the cardiovascular system: evidence for common signaling pathways.","authors":"Dwitiya Sawant, Brenda Lilly","doi":"10.1530/VB-20-0012","DOIUrl":"https://doi.org/10.1530/VB-20-0012","url":null,"abstract":"<p><p>miRNAs are small regulatory RNAs which govern gene expression post-transcriptionally by primarily binding to the 3'-UTR of mRNA target genes. miR-145 is a well-studied miRNA that has been implicated in controlling a range of biological processes. miR-145 is expressed in a variety of tissues and cell types and acts as a tumor-suppressor by regulating target gene signaling pathways involved in different aspects of tumor growth and progression. There is also strong evidence that highlights the important functions of miR-145 in the cardiovascular system. Here, we review the mechanisms of miR-145 in tumorigenesis and cancer progression and compare and contrast with the roles of miR-145 in cardiovascular development and disease. We discuss the important targets of miR-145 in cancer and their possible link to the cardiovascular system.</p>","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"R115-R128"},"PeriodicalIF":0.0,"publicationDate":"2020-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e9/3f/VB-20-0012.PMC7709916.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38680055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-20eCollection Date: 2020-01-01DOI: 10.1530/VB-20-0009
Abdallah Al-Mohammad, David G Partridge, Graham Fent, Oliver Watson, Nigel T Lewis, Robert F Storey, Michael Makris, Timothy J Chico
Since the first description of COVID-19 in December 2019, more than 63,000 publications have described its virology, clinical course, management, treatment and prevention. Most physicians are now encountering, or will soon encounter, patients with COVID-19 and must attempt to simultaneously assimilate this avalanche of information while managing an entirely novel disease with few guiding precedents. It is increasingly clear that, although primarily a respiratory illness, COVID-19 is associated with cardiovascular complications. However, the true incidence of direct cardiac complications remains unclear, as all complications thus far reported can also occur in patients without COVID-19. In this review, we briefly summarise and critically appraise the data on cardiac complications associated with COVID-19 and describe some cases from our own experience. We identify unresolved questions and highlight the many uncertainties in this developing field.
{"title":"The cardiac complications of COVID-19: many publications, multiple uncertainties.","authors":"Abdallah Al-Mohammad, David G Partridge, Graham Fent, Oliver Watson, Nigel T Lewis, Robert F Storey, Michael Makris, Timothy J Chico","doi":"10.1530/VB-20-0009","DOIUrl":"10.1530/VB-20-0009","url":null,"abstract":"<p><p>Since the first description of COVID-19 in December 2019, more than 63,000 publications have described its virology, clinical course, management, treatment and prevention. Most physicians are now encountering, or will soon encounter, patients with COVID-19 and must attempt to simultaneously assimilate this avalanche of information while managing an entirely novel disease with few guiding precedents. It is increasingly clear that, although primarily a respiratory illness, COVID-19 is associated with cardiovascular complications. However, the true incidence of direct cardiac complications remains unclear, as all complications thus far reported can also occur in patients without COVID-19. In this review, we briefly summarise and critically appraise the data on cardiac complications associated with COVID-19 and describe some cases from our own experience. We identify unresolved questions and highlight the many uncertainties in this developing field.</p>","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"R105-R114"},"PeriodicalIF":0.0,"publicationDate":"2020-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/46/ed/VB-20-0009.PMC7709917.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38680053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-24DOI: 10.1101/2020.07.23.216192
E. Kugler, Ryan O. Snodgrass, George Bowley, K. Plant, J. Serbanovic-Canic, P. Evans, T. Chico, P. Armitage
The role of blood flow is complex and context-dependent. In this study, we quantify the effect of the lack of blood flow on vascular development and compare its impact in two vascular beds, namely the cerebral and trunk vasculature, using zebrafish as preclinical model. We performed this by analysing vascular topology, endothelial cell number, apoptosis, and inflammatory response in animals with normal blood flow or absent blood flow. We find that absent blood flow reduced vascular area and endothelial cell number significantly in both examined vascular beds, but the effect is more severe in the cerebral vasculature. Similarly, while stereotypic vascular patterning in the trunk is maintained, intra-cerebral vessels show altered patterning. Absent blood flow lead to an increase in non-EC-specific apoptosis without increasing tissue inflammation, as quantified by cerebral immune cell numbers and nitric oxide. In conclusion, blood flow is essential for cellular survival in both the trunk and cerebral vasculature, but particularly intra-cerebral vessels are affected by the lack of blood flow, suggesting that responses to blood flow differ between these two vascular beds. Key points We here use zebrafish as a model to quantitatively assess the impact of the lack of blood flow in development and compare its impact in two vascular beds, namely the cerebral to trunk vasculature. In both vascular beds, vascular growth and endothelial cell number are reduced by lack of blood flow, with increasing effect size from 2-5 days post fertilisation. Examination of vascular patterning shows that while stereotypic patterning in the trunk is preserved, the intra-cerebral vasculature patterning is altered. We found non-EC-specific cell death to be increased in both vascular beds, with a larger effect size in the brain, but that this cell death occurs without triggering tissue inflammation.
{"title":"The effect of absent blood flow on the zebrafish cerebral and trunk vasculature","authors":"E. Kugler, Ryan O. Snodgrass, George Bowley, K. Plant, J. Serbanovic-Canic, P. Evans, T. Chico, P. Armitage","doi":"10.1101/2020.07.23.216192","DOIUrl":"https://doi.org/10.1101/2020.07.23.216192","url":null,"abstract":"The role of blood flow is complex and context-dependent. In this study, we quantify the effect of the lack of blood flow on vascular development and compare its impact in two vascular beds, namely the cerebral and trunk vasculature, using zebrafish as preclinical model. We performed this by analysing vascular topology, endothelial cell number, apoptosis, and inflammatory response in animals with normal blood flow or absent blood flow. We find that absent blood flow reduced vascular area and endothelial cell number significantly in both examined vascular beds, but the effect is more severe in the cerebral vasculature. Similarly, while stereotypic vascular patterning in the trunk is maintained, intra-cerebral vessels show altered patterning. Absent blood flow lead to an increase in non-EC-specific apoptosis without increasing tissue inflammation, as quantified by cerebral immune cell numbers and nitric oxide. In conclusion, blood flow is essential for cellular survival in both the trunk and cerebral vasculature, but particularly intra-cerebral vessels are affected by the lack of blood flow, suggesting that responses to blood flow differ between these two vascular beds. Key points We here use zebrafish as a model to quantitatively assess the impact of the lack of blood flow in development and compare its impact in two vascular beds, namely the cerebral to trunk vasculature. In both vascular beds, vascular growth and endothelial cell number are reduced by lack of blood flow, with increasing effect size from 2-5 days post fertilisation. Examination of vascular patterning shows that while stereotypic patterning in the trunk is preserved, the intra-cerebral vasculature patterning is altered. We found non-EC-specific cell death to be increased in both vascular beds, with a larger effect size in the brain, but that this cell death occurs without triggering tissue inflammation.","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"3 1","pages":"1 - 16"},"PeriodicalIF":0.0,"publicationDate":"2020-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45736012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-21eCollection Date: 2020-01-01DOI: 10.1530/VB-20-0003
Kor H Hutting, Wouter B Aan de Stegge, Rombout R Kruse, Jeff G van Baal, Sicco A Bus, Jaap J van Netten
Monitoring of diabetic foot infections is largely based on clinical assessment, which is limited by moderate reliability. We conducted a prospective study to explore monitoring of thermal asymmetry (difference between mean plantar temperature of the affected and unaffected foot) for the assessment of severity of diabetic foot infections. In patients with moderate or severe diabetic foot infections (International Working Group on the Diabetic Foot infection-grades 3 or 4) we measured thermal asymmetry with an advanced infrared thermography setup during the first 4-5 days of in-hospital treatment, in addition to clinical assessments and tests of serum inflammatory markers (white blood cell counts and C-reactive protein levels). We assessed the change in thermal asymmetry from baseline to final assessment, and investigated its association with infection-grades and serum inflammatory markers. In seven included patients, thermal asymmetry decreased from median 1.8°C (range: -0.6 to 8.4) at baseline to 1.5°C (range: -0.1 to 5.1) at final assessment (P = 0.515). In three patients who improved to infection-grade 2, thermal asymmetry at baseline (median 1.6°C (range: -0.6 to 1.6)) and final assessment (1.5°C (range: 0.4 to 5.1)) remained similar (P = 0.302). In four patients who did not improve to infection-grade 2, thermal asymmetry decreased from median 4.3°C (range: 1.8 to 8.4) to 1.9°C (range: -0.1 to 4.4; P = 0.221). No correlations were found between thermal asymmetry and infection-grades (r = -0.347; P = 0.445), CRP-levels (r = 0.321; P = 0.482) or WBC (r = -0.250; P = 0.589) during the first 4-5 days of hospitalization. Based on these explorative findings we suggest that infrared thermography is of no value for monitoring diabetic foot infections during in-hospital treatment.
{"title":"Infrared thermography for monitoring severity and treatment of diabetic foot infections.","authors":"Kor H Hutting, Wouter B Aan de Stegge, Rombout R Kruse, Jeff G van Baal, Sicco A Bus, Jaap J van Netten","doi":"10.1530/VB-20-0003","DOIUrl":"10.1530/VB-20-0003","url":null,"abstract":"<p><p>Monitoring of diabetic foot infections is largely based on clinical assessment, which is limited by moderate reliability. We conducted a prospective study to explore monitoring of thermal asymmetry (difference between mean plantar temperature of the affected and unaffected foot) for the assessment of severity of diabetic foot infections. In patients with moderate or severe diabetic foot infections (International Working Group on the Diabetic Foot infection-grades 3 or 4) we measured thermal asymmetry with an advanced infrared thermography setup during the first 4-5 days of in-hospital treatment, in addition to clinical assessments and tests of serum inflammatory markers (white blood cell counts and C-reactive protein levels). We assessed the change in thermal asymmetry from baseline to final assessment, and investigated its association with infection-grades and serum inflammatory markers. In seven included patients, thermal asymmetry decreased from median 1.8°C (range: -0.6 to 8.4) at baseline to 1.5°C (range: -0.1 to 5.1) at final assessment (<i>P</i> = 0.515). In three patients who improved to infection-grade 2, thermal asymmetry at baseline (median 1.6°C (range: -0.6 to 1.6)) and final assessment (1.5°C (range: 0.4 to 5.1)) remained similar (<i>P</i> = 0.302). In four patients who did not improve to infection-grade 2, thermal asymmetry decreased from median 4.3°C (range: 1.8 to 8.4) to 1.9°C (range: -0.1 to 4.4<i>; P</i> = 0.221). No correlations were found between thermal asymmetry and infection-grades (<i>r</i> = -0.347; <i>P</i> = 0.445), CRP-levels (<i>r</i> = 0.321; <i>P</i> = 0.482) or WBC (<i>r</i> = -0.250; <i>P</i> = 0.589) during the first 4-5 days of hospitalization. Based on these explorative findings we suggest that infrared thermography is of no value for monitoring diabetic foot infections during in-hospital treatment.</p>","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"1-10"},"PeriodicalIF":0.0,"publicationDate":"2020-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/aa/VB-20-0003.PMC7487596.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38483744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-02eCollection Date: 2020-01-01DOI: 10.1530/VB-20-0007
Catarina G Fonseca, Pedro Barbacena, Claudio A Franco
The vascular system is a hierarchically organized network of blood vessels that play crucial roles in embryogenesis, homeostasis and disease. Blood vessels are built by endothelial cells - the cells lining the interior of blood vessels - through a process named vascular morphogenesis. Endothelial cells react to different biomechanical signals in their environment by adjusting their behavior to: (1) invade, proliferate and fuse to form new vessels (angiogenesis); (2) remodel, regress and establish a hierarchy in the network (patterning); and (3) maintain network stability (quiescence). Each step involves the coordination of endothelial cell differentiation, proliferation, polarity, migration, rearrangements and shape changes to ensure network integrity and an efficient barrier between blood and tissues. In this review, we highlighted the relevance and the mechanisms involving endothelial cell migration during different steps of vascular morphogenesis. We further present evidence on how impaired endothelial cell dynamics can contribute to pathology.
{"title":"Endothelial cells on the move: dynamics in vascular morphogenesis and disease.","authors":"Catarina G Fonseca, Pedro Barbacena, Claudio A Franco","doi":"10.1530/VB-20-0007","DOIUrl":"https://doi.org/10.1530/VB-20-0007","url":null,"abstract":"<p><p>The vascular system is a hierarchically organized network of blood vessels that play crucial roles in embryogenesis, homeostasis and disease. Blood vessels are built by endothelial cells - the cells lining the interior of blood vessels - through a process named vascular morphogenesis. Endothelial cells react to different biomechanical signals in their environment by adjusting their behavior to: (1) invade, proliferate and fuse to form new vessels (angiogenesis); (2) remodel, regress and establish a hierarchy in the network (patterning); and (3) maintain network stability (quiescence). Each step involves the coordination of endothelial cell differentiation, proliferation, polarity, migration, rearrangements and shape changes to ensure network integrity and an efficient barrier between blood and tissues. In this review, we highlighted the relevance and the mechanisms involving endothelial cell migration during different steps of vascular morphogenesis. We further present evidence on how impaired endothelial cell dynamics can contribute to pathology.</p>","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"H29-H43"},"PeriodicalIF":0.0,"publicationDate":"2020-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/f3/VB-20-0007.PMC7487603.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38483746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The role of mitochondria in cardiac tissue is of utmost importance due to the dynamic nature of the heart and its energetic demands, necessary to assure its proper beating function. Recently, other important mitochondrial roles have been discovered, namely its contribution to intracellular calcium handling in normal and pathological myocardium. Novel investigations support the fact that during the progression toward heart failure, mitochondrial calcium machinery is compromised due to its morphological, structural and biochemical modifications resulting in facilitated arrhythmogenesis and heart failure development. The interaction between mitochondria and sarcomere directly affect cardiomyocyte excitation-contraction and is also involved in mechano-transduction through the cytoskeletal proteins that tether together the mitochondria and the sarcoplasmic reticulum. The focus of this review is to briefly elucidate the role of mitochondria as (mechano) sensors in the heart.
{"title":"Mitochondrial mechanosensor in cardiovascular diseases.","authors":"Cristina Caffarra Malvezzi, Aderville Cabassi, Michele Miragoli","doi":"10.1530/VB-20-0002","DOIUrl":"https://doi.org/10.1530/VB-20-0002","url":null,"abstract":"<p><p>The role of mitochondria in cardiac tissue is of utmost importance due to the dynamic nature of the heart and its energetic demands, necessary to assure its proper beating function. Recently, other important mitochondrial roles have been discovered, namely its contribution to intracellular calcium handling in normal and pathological myocardium. Novel investigations support the fact that during the progression toward heart failure, mitochondrial calcium machinery is compromised due to its morphological, structural and biochemical modifications resulting in facilitated arrhythmogenesis and heart failure development. The interaction between mitochondria and sarcomere directly affect cardiomyocyte excitation-contraction and is also involved in mechano-transduction through the cytoskeletal proteins that tether together the mitochondria and the sarcoplasmic reticulum. The focus of this review is to briefly elucidate the role of mitochondria as (mechano) sensors in the heart.</p>","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"R85-R92"},"PeriodicalIF":0.0,"publicationDate":"2020-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/ae/VB-20-0002.PMC7439846.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38374990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-22eCollection Date: 2020-01-01DOI: 10.1530/VB-20-0006
Karthik Amudhala Hemanthakumar, Riikka Kivelä
Endothelial cells (ECs) line the inner surface of all blood and lymphatic vessels throughout the body, making endothelium one of the largest tissues. In addition to its transport function, endothelium is now appreciated as a dynamic organ actively participating in angiogenesis, permeability and vascular tone regulation, as well as in the development and regeneration of tissues. The identification of endothelial-derived secreted factors, angiocrines, has revealed non-angiogenic mechanisms of endothelial cells in both physiological and pathological tissue remodeling. In the heart, ECs play a variety of important roles during cardiac development as well as in growth, homeostasis and regeneration of the adult heart. To date, several angiocrines affecting cardiomyocyte growth in response to physiological or pathological stimuli have been identified. In this review, we discuss the effects of angiogenesis and EC-mediated signaling in the regulation of cardiac hypertrophy. Identification of the molecular and metabolic signals from ECs during physiological and pathological cardiac growth could provide novel therapeutic targets to treat heart failure, as endothelium is emerging as one of the potential target organs in cardiovascular and metabolic diseases.
{"title":"Angiogenesis and angiocrines regulating heart growth.","authors":"Karthik Amudhala Hemanthakumar, Riikka Kivelä","doi":"10.1530/VB-20-0006","DOIUrl":"https://doi.org/10.1530/VB-20-0006","url":null,"abstract":"<p><p>Endothelial cells (ECs) line the inner surface of all blood and lymphatic vessels throughout the body, making endothelium one of the largest tissues. In addition to its transport function, endothelium is now appreciated as a dynamic organ actively participating in angiogenesis, permeability and vascular tone regulation, as well as in the development and regeneration of tissues. The identification of endothelial-derived secreted factors, angiocrines, has revealed non-angiogenic mechanisms of endothelial cells in both physiological and pathological tissue remodeling. In the heart, ECs play a variety of important roles during cardiac development as well as in growth, homeostasis and regeneration of the adult heart. To date, several angiocrines affecting cardiomyocyte growth in response to physiological or pathological stimuli have been identified. In this review, we discuss the effects of angiogenesis and EC-mediated signaling in the regulation of cardiac hypertrophy. Identification of the molecular and metabolic signals from ECs during physiological and pathological cardiac growth could provide novel therapeutic targets to treat heart failure, as endothelium is emerging as one of the potential target organs in cardiovascular and metabolic diseases.</p>","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"R93-R104"},"PeriodicalIF":0.0,"publicationDate":"2020-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8d/9a/VB-20-0006.PMC7487598.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38483747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-15eCollection Date: 2020-01-01DOI: 10.1530/VB-20-0010
Paolo Madeddu
{"title":"Shifting to a circular approach in publishing research data: new opportunities to develop and promote ideas and curricula in vascular biology.","authors":"Paolo Madeddu","doi":"10.1530/VB-20-0010","DOIUrl":"https://doi.org/10.1530/VB-20-0010","url":null,"abstract":"","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"E7-E9"},"PeriodicalIF":0.0,"publicationDate":"2020-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/d1/VB-20-0010.PMC7439837.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38377584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-15eCollection Date: 2020-01-01DOI: 10.1530/VB-20-0005
Manisha S Patil, Siân P Cartland, Mary M Kavurma
The extracellular matrix (ECM) is an essential part of the vasculature, not only providing structural support to the blood vessel wall, but also in its ability to interact with cells to regulate cell phenotype and function including proliferation, migration, differentiation and death - processes important in vascular remodelling. Increasing evidence implicates TNF-related apoptosis-inducing ligand (TRAIL) signalling in the modulation of vascular cell function and remodelling under normal and pathological conditions such as in atherosclerosis. TRAIL can also stimulate synthesis of multiple ECM components within blood vessels. This review explores the relationship between TRAIL signals, the ECM, and its implications in vessel remodelling in cardiovascular disease.
{"title":"TRAIL signals, extracellular matrix and vessel remodelling.","authors":"Manisha S Patil, Siân P Cartland, Mary M Kavurma","doi":"10.1530/VB-20-0005","DOIUrl":"https://doi.org/10.1530/VB-20-0005","url":null,"abstract":"<p><p>The extracellular matrix (ECM) is an essential part of the vasculature, not only providing structural support to the blood vessel wall, but also in its ability to interact with cells to regulate cell phenotype and function including proliferation, migration, differentiation and death - processes important in vascular remodelling. Increasing evidence implicates TNF-related apoptosis-inducing ligand (TRAIL) signalling in the modulation of vascular cell function and remodelling under normal and pathological conditions such as in atherosclerosis. TRAIL can also stimulate synthesis of multiple ECM components within blood vessels. This review explores the relationship between TRAIL signals, the ECM, and its implications in vessel remodelling in cardiovascular disease.</p>","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"R73-R84"},"PeriodicalIF":0.0,"publicationDate":"2020-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/97/VB-20-0005.PMC7439926.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38374989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-08eCollection Date: 2020-01-01DOI: 10.1530/VB-20-0008
Paolo Madeddu
On June 01, 2020, the outbreak of COVID-19 caused by SARS-CoV-2 has escalated to 6.3 million cases worldwide, including 374,000 deaths. Severe lung disease with acute respiratory distress syndrome represents one of the most common complications. Additionally, myocardial injury is present in more than a quarter of critical cases, manifesting either acutely on presentation or more insidiously as illness severity intensifies (1, 2, 3, 4). Clinical signs of cardiovascular disease include chest pain, fulminant myocarditis, arrhythmias, acute coronary artery disease, and heart failure. More recently, microvascular disease syndromes have been reported, including cutaneous reticular livedo (5, 6). Some cases of Kawasaki disease, in which blood vessels throughout the body become inflamed and can form aneurysms, have been also reported. However, this figure is lower than would be normally expected at this time of year when Kawasaki disease generally peaks (https://www.rcpch. ac.uk/news-events/news/college-responds-recent-reportscovid-19-children). Media articles on Kawasaki disease were confusing and have caused public concern. This calls for cautious interpretation and communication of research outputs, a difficult task in a global emergency requiring immediate medical solutions. Two COVID-19 priority studies in the UK (DIAMONDS (Central Portfolio Management System 45537) and ISARIC (UK Clinical Research Network 14152)) are collaborating in a study exploring prevalence of the disease and underpinning mechanisms. Researchers around the world are racing to learn how the virus behaves and which health factors put people most at risk. The crucial question they are trying to work out is whether there may be some specific mechanism in cells of the lung and heart that could mean some people suffer respiratory complications and heart attacks more than others. While the increased frailty of cardiovascular patients may account for the susceptibility to infection and organ damage, the reason why COVID-19 causes cardiovascular complications is less obvious. SARS-CoV-2 has adopted a successful tactic to infect, damage, and spread. The virus binds with its spike protein to the surface receptor angiotensin converting enzyme 2 (ACE2) to unlock human cells and begin infection. We know relatively little of the stoichiometry of the virus – human cell receptor interaction. The minimum number necessary for infection varies between different viruses and it is not clear what is minimum infectious dose for COVID-19. Likewise, it remains to be established whether repeated exposures or a single contact with massive doses of the virus, like in the case of clinical staff caring patients who are not known to be infected, can increase the risk of developing severe forms of the disease. The second element to consider is the binding affinity of the viral spike protein for the human cell receptor. The binding of SARS-CoV-2 to ACE2 is stronger than previous coronaviruses, due to differenc
{"title":"Cardiovascular complications of COVID-19: evidence, misconceptions, and new opportunities.","authors":"Paolo Madeddu","doi":"10.1530/VB-20-0008","DOIUrl":"https://doi.org/10.1530/VB-20-0008","url":null,"abstract":"On June 01, 2020, the outbreak of COVID-19 caused by SARS-CoV-2 has escalated to 6.3 million cases worldwide, including 374,000 deaths. Severe lung disease with acute respiratory distress syndrome represents one of the most common complications. Additionally, myocardial injury is present in more than a quarter of critical cases, manifesting either acutely on presentation or more insidiously as illness severity intensifies (1, 2, 3, 4). Clinical signs of cardiovascular disease include chest pain, fulminant myocarditis, arrhythmias, acute coronary artery disease, and heart failure. More recently, microvascular disease syndromes have been reported, including cutaneous reticular livedo (5, 6). Some cases of Kawasaki disease, in which blood vessels throughout the body become inflamed and can form aneurysms, have been also reported. However, this figure is lower than would be normally expected at this time of year when Kawasaki disease generally peaks (https://www.rcpch. ac.uk/news-events/news/college-responds-recent-reportscovid-19-children). Media articles on Kawasaki disease were confusing and have caused public concern. This calls for cautious interpretation and communication of research outputs, a difficult task in a global emergency requiring immediate medical solutions. Two COVID-19 priority studies in the UK (DIAMONDS (Central Portfolio Management System 45537) and ISARIC (UK Clinical Research Network 14152)) are collaborating in a study exploring prevalence of the disease and underpinning mechanisms. Researchers around the world are racing to learn how the virus behaves and which health factors put people most at risk. The crucial question they are trying to work out is whether there may be some specific mechanism in cells of the lung and heart that could mean some people suffer respiratory complications and heart attacks more than others. While the increased frailty of cardiovascular patients may account for the susceptibility to infection and organ damage, the reason why COVID-19 causes cardiovascular complications is less obvious. SARS-CoV-2 has adopted a successful tactic to infect, damage, and spread. The virus binds with its spike protein to the surface receptor angiotensin converting enzyme 2 (ACE2) to unlock human cells and begin infection. We know relatively little of the stoichiometry of the virus – human cell receptor interaction. The minimum number necessary for infection varies between different viruses and it is not clear what is minimum infectious dose for COVID-19. Likewise, it remains to be established whether repeated exposures or a single contact with massive doses of the virus, like in the case of clinical staff caring patients who are not known to be infected, can increase the risk of developing severe forms of the disease. The second element to consider is the binding affinity of the viral spike protein for the human cell receptor. The binding of SARS-CoV-2 to ACE2 is stronger than previous coronaviruses, due to differenc","PeriodicalId":75294,"journal":{"name":"Vascular biology (Bristol, England)","volume":"2 1","pages":"E3-E6"},"PeriodicalIF":0.0,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/49/96/VB-20-0008.PMC7439917.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38377581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}